Author

Haluk Tarik Kani

Transmural remission improves clinical outcomes up to 5 years in Crohn's disease
Transmural remission improves clinical outcomes up to 5 years in Crohn's disease

Haluk Tarik Kani  et al.

Comparison of two strategies for the management of postoperative recurrence in Crohn’s disease patients with one clinical risk factor
Comparison of two strategies for the management of postoperative recurrence in Crohn’s disease patients with one clinical risk factor

Haluk Tarik Kani  et al.

Ustekinumab improves health‐related quality of life in patients with moderate‐to‐severe Crohn's disease: STARDUST trial
Ustekinumab improves health‐related quality of life in patients with moderate‐to‐severe Crohn's disease: STARDUST trial

Haluk Tarik Kani  et al.

Smoking and colorectal neoplasia in patients with inflammatory bowel disease: Dose-effect relationship
Smoking and colorectal neoplasia in patients with inflammatory bowel disease: Dose-effect relationship

Haluk Tarik Kani  et al.

EVALUATION OF SPLEEN STIFFNESS IN HEALTHY POPULATION: A VIBRATION-CONTROLLED TRANSIENT ELASTOGRAPHY STUDY
EVALUATION OF SPLEEN STIFFNESS IN HEALTHY POPULATION: A VIBRATION-CONTROLLED TRANSIENT ELASTOGRAPHY STUDY

Toward a more precise prognostic stratification in acute decompensation of cirrhosis: The Padua model 2.0.
Toward a more precise prognostic stratification in acute decompensation of cirrhosis: The Padua model 2.0.

Haluk Tarik Kani  et al.

EVALUATION OF SPLEEN STIFFNESS IN HEALTHY POPULATION: A VIBRATION-CONTROLLED TRANSIENT ELASTOGRAPHY STUDY
EVALUATION OF SPLEEN STIFFNESS IN HEALTHY POPULATION: A VIBRATION-CONTROLLED TRANSIENT ELASTOGRAPHY STUDY

Haluk Tarik Kani  et al.

EVALUATION OF ACUTE INFLAMMATORY AND STRUCTURAL CHANGES OF SACROILIITIS ON MR ENTEROGRAPHY: A DIRECT COMPARISON WITH SACROILIAC JOINT MRI
EVALUATION OF ACUTE INFLAMMATORY AND STRUCTURAL CHANGES OF SACROILIITIS ON MR ENTEROGRAPHY: A DIRECT COMPARISON WITH SACROILIAC JOINT MRI

Haluk Tarik Kani  et al.

OUTCOMES OF ANTI-TNF TREATMENT IN CROHN’S DISEASE: A REAL LIFE, TERTIARY CENTER EXPERIENCE
OUTCOMES OF ANTI-TNF TREATMENT IN CROHN’S DISEASE: A REAL LIFE, TERTIARY CENTER EXPERIENCE

Haluk Tarik Kani  et al.

PREDICTING FIBROSIS PROGRESSION IN NON-ALCOHOLIC FATTY LIVER DISEASE PATIENTS USING FAST SCORE: A PAIRED BIOPSY STUDY
PREDICTING FIBROSIS PROGRESSION IN NON-ALCOHOLIC FATTY LIVER DISEASE PATIENTS USING FAST SCORE: A PAIRED BIOPSY STUDY

Haluk Tarik Kani  et al.

PARAMETERS AFFECTING FISTULA TREATMENT RESPONSE IN PERIANAL FISTULIZING CROHN’S DISEASE UNDER BIOLOGICAL THERAPY: A MACHINE LEARNING MODEL STUDY
PARAMETERS AFFECTING FISTULA TREATMENT RESPONSE IN PERIANAL FISTULIZING CROHN’S DISEASE UNDER BIOLOGICAL THERAPY: A MACHINE LEARNING MODEL STUDY

Haluk Tarik Kani  et al.

Interactive Insights With Your UEG Podcast Hosts: UEGW Special
Interactive Insights With Your UEG Podcast Hosts: UEGW Special

Haluk Tarik Kani  et al.

HIGH INCIDENCE OF HEPATITIS B CORE ANTIBODY POSITIVITY IN METABOLIC-ASSOCIATED FATTY LIVER DISEASE-RELATED CIRRHOSIS
HIGH INCIDENCE OF HEPATITIS B CORE ANTIBODY POSITIVITY IN METABOLIC-ASSOCIATED FATTY LIVER DISEASE-RELATED CIRRHOSIS

Haluk Tarik Kani  et al.

DECREASED MUSCLE MASS AND STRENGTH IN INFLAMMATORY BOWEL DISEASE PATIENTS
DECREASED MUSCLE MASS AND STRENGTH IN INFLAMMATORY BOWEL DISEASE PATIENTS

Haluk Tarik Kani  et al.

LARGE DIFFERENCES IN IBD CARE AND EDUCATION ACROSS EUROPE, FIRST RESULTS OF THE PAN-EUROPEAN VIPER SURVEY
LARGE DIFFERENCES IN IBD CARE AND EDUCATION ACROSS EUROPE, FIRST RESULTS OF THE PAN-EUROPEAN VIPER SURVEY

Haluk Tarik Kani  et al.

Item 1 - 15 / 15
1